-+ 0.00%
-+ 0.00%
-+ 0.00%

Press Release: BioVaxys Acquires All Intellectual Property, Immunotherapeutics Platform Technology, and Clinical Stage Assets of the Former IMV Inc.

Dow Jones·02/12/2024 19:18:00

Please log in to view news